Literature DB >> 26290607

Defending the Use of Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment for Malaria in Pregnancy: A Short-Sighted Strategy.

Whitney E Harrington1, Michal Fried2, Patrick E Duffy2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26290607      PMCID： PMC4704669          DOI： 10.1093/infdis/jiv420

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women.

Authors:  Julie Gutman; Linda Kalilani; Steve Taylor; Zhiyong Zhou; Ryan E Wiegand; Kyaw L Thwai; Dyson Mwandama; Carole Khairallah; Mwayi Madanitsa; Ebbie Chaluluka; Fraction Dzinjalamala; Doreen Ali; Don P Mathanga; Jacek Skarbinski; Ya Ping Shi; Steve Meshnick; Feiko O ter Kuile
Journal:  J Infect Dis       Date:  2015-01-06       Impact factor: 5.226

2.  Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.

Authors:  Steve M Taylor; Alejandro L Antonia; Ebbie Chaluluka; Victor Mwapasa; Gaoqian Feng; Malcolm E Molyneux; Feiko O ter Kuile; Steven R Meshnick; Stephen J Rogerson
Journal:  Clin Infect Dis       Date:  2012-03-22       Impact factor: 9.079

3.  Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance.

Authors:  Whitney E Harrington; Theonest K Mutabingwa; Edward Kabyemela; Michal Fried; Patrick E Duffy
Journal:  Clin Infect Dis       Date:  2011-08-01       Impact factor: 9.079

4.  Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets.

Authors:  Gaoqian Feng; Julie A Simpson; Ebbie Chaluluka; Malcolm E Molyneux; Stephen J Rogerson
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

5.  Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment.

Authors:  W E Harrington; T K Mutabingwa; A Muehlenbachs; B Sorensen; M C Bolla; M Fried; P E Duffy
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-18       Impact factor: 11.205

6.  Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model.

Authors:  Andrew R Wargo; Silvie Huijben; Jacobus C de Roode; James Shepherd; Andrew F Read
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-03       Impact factor: 11.205

7.  A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic.

Authors:  Clara Menéndez; Azucena Bardají; Betuel Sigauque; Cleofé Romagosa; Sergi Sanz; Elisa Serra-Casas; Eusebio Macete; Anna Berenguera; Catarina David; Carlota Dobaño; Denise Naniche; Alfredo Mayor; Jaume Ordi; Inacio Mandomando; John J Aponte; Samuel Mabunda; Pedro L Alonso
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240
  7 in total
  1 in total

1.  Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.

Authors:  Patrick G T Walker; Jessica Floyd; Feiko Ter Kuile; Matt Cairns
Journal:  PLoS Med       Date:  2017-02-28       Impact factor: 11.069
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.